Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: February 10, 2016
Reporting Period: Quarter and nine months ended December 31, 2015
Context: The registrant is furnishing public disclosures regarding its results of operations and financial condition. The results were announced on February 9, 2016, under International Financial Reporting Standards (IFRS).
Key Financial Metrics
The provided filing text serves as a cover document referencing attached exhibits for detailed financial data. It does not contain specific numerical values for the following metrics:
- Revenue
- Profit
- Cash Flow
- Margins
- Debt
- Liquidity
Note: Specific financial figures are contained in the attached exhibits (Exhibit 99.1, 99.2, and 99.3) which are not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release and financial statements for comparative analysis.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, contingencies, or unusual items. It solely confirms the availability of the results on the company website (www.drreddys.com) and the attachment of the relevant reports.
Investor Verification Checklist
- Verify the specific revenue and profit figures in the attached Exhibit 99.1 (Press Release) and Exhibit 99.3 (IFRS Consolidated Results).
- Review the Exhibit 99.2 for Indian GAAP Unaudited Standalone Financial Results to compare with IFRS consolidated figures.
- Confirm the details of the review reports mentioned in the filing.
- Check the company website for the full text of the press release dated February 9, 2016.